Artificial heart This technologically advanced pneumatic Phoenix-7 Total Artificial Heart was manufactured by a Taiwanese dentist Kelvin K. Cheng, a Chinese physician T. M. Kao and colleagues at the Taiwan TAH Research Center in Tainan, Republic of China (Taiwan). With this experimental artificial heart, the patient's BP was maintained at 90-100/40-55 mmHg and cardiac output at 4.2–5.8 L/min. The patient then received the world's first successful combined heart and kidney transplantation after bridging with a total artificial heart. The first AbioCor to be surgically implanted in a patient was on July 3, 2001. SynCardia is a company based in Tucson, Arizona which
Artificial kidney approvals in other areas. The Kidney Project is a national research initiative that focuses on the development and testing of an implanted, freestanding bioartifical kidney. The Kidney Project received six million dollars in government grants. Artificial kidney Artificial kidney is often a synonym for hemodialysis, but may also, refer to renal replacement therapies (with exclusion of kidney transplantation) that are in use and/or in development. This article deals with bioengineered kidneys/bioartificial kidneys that are grown from renal cell lines/renal tissue. The first successful artificial kidney was developed by Willem Kolff in the Netherlands during the early 1940s. Kolff was the